{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:41:14Z","timestamp":1787060474093,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,7,4]],"date-time":"2016-07-04T00:00:00Z","timestamp":1467590400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["GGP13036"],"award-info":[{"award-number":["GGP13036"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007109","name":"Universit\u00e0 degli Studi di Ferrara","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ijpharm.2016.07.002","type":"journal-article","created":{"date-parts":[[2016,11,15]],"date-time":"2016-11-15T08:33:52Z","timestamp":1479198832000},"page":"229-237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Nasal powders of thalidomide for local treatment of nose bleeding in persons affected by hereditary hemorrhagic telangiectasia"],"prefix":"10.1016","volume":"514","author":[{"given":"G.","family":"Colombo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bortolotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Chiapponi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Buttini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Sonvico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Invernizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Quaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Danesino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Pagella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Bettini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1480-753X","authenticated-orcid":false,"given":"A.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2016.07.002_bib0005","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.ejpb.2008.06.024","article-title":"Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation","volume":"70","author":"Badr-Eldin","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2016.07.002_bib0010","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijpharm.2012.09.049","article-title":"Antidiuretic effect of desmopressin chimera agglomerates by nasal administration in rats","volume":"440","author":"Balducci","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.07.002_bib0015","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0378-5173(92)90235-T","article-title":"The viability of isolated rabbit nasal mucosa in the Ussing chamber, and the permeability of insulin across the membrane","volume":"87","author":"Bechgaard","year":"1992","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.07.002_bib0020","first-page":"457","article-title":"Nicotine nasal powder: design and characterization","volume":"9","author":"Bettini","year":"1999","journal-title":"S.T.P Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.07.002_bib0025","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejps.2008.12.015","article-title":"In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays: the enhancing effect of potassium sorbate","volume":"37","author":"Bortolotti","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.07.002_bib0030","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jconrel.2012.02.028","article-title":"Particles and powders: tools of innovation for non-invasive drug administration","volume":"161","author":"Buttini","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2016.07.002_bib0035","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3109\/03639045.2012.707210","article-title":"Development of in vitro models to demonstrate the ability of PecSys\u00ae, an in situ nasal gelling technology, to reduce nasal run-off and drip","volume":"39","author":"Castile","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2016.07.002_bib0040","doi-asserted-by":"crossref","first-page":"E329","DOI":"10.1208\/pt060243","article-title":"Cyclodextrins in drug delivery: an updated review","volume":"6","author":"Challa","year":"2005","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2016.07.002_bib0045","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.antiviral.2011.09.012","article-title":"Brain distribution of ribavirin after intranasal administration","volume":"92","author":"Colombo","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.ijpharm.2016.07.002_bib0050","doi-asserted-by":"crossref","first-page":"5788","DOI":"10.1016\/j.bmc.2008.03.057","article-title":"Sulfadiazine\/hydroxypropyl-beta-cyclodextrin host-guest system: characterization, phase-solubility and molecular modeling","volume":"16","author":"de Araujo","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ijpharm.2016.07.002_bib0055","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1023\/A:1016099516757","article-title":"Delivery of nasal powders of beta-cyclodextrin by insufflation","volume":"13","author":"De Ascentiis","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2016.07.002_bib0060","unstructured":"European Medicines Agency: EMEA\/CHMP\/QWP\/49313\/2005 Corr \u2212 GUIDELINE ON THE PHARMACEUTICAL QUALITY OF INHALATION AND NASAL PRODUCTS2006. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500003568.pdf, May 2016."},{"key":"10.1016\/j.ijpharm.2016.07.002_bib0065","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijpharm.2007.08.038","article-title":"Influence of sulfobutyl ether beta-cyclodextrin (captisol) on the dissolution properties of a poorly soluble drug from extrudates prepared by hot-melt extrusion","volume":"350","author":"Fukuda","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.07.002_bib0070","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1023\/A:1013643013244","article-title":"Physicochemical characterization and solubility analysis of thalidomide and its N-alkyl analogs","volume":"19","author":"Goosen","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2016.07.002_bib0075","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/ejhg.2009.35","article-title":"Hereditary hemorrhagic telangiectasia: a clinical and scientific review","volume":"17","author":"Govani","year":"2009","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ijpharm.2016.07.002_bib0080","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1056\/NEJM199510053331407","article-title":"Hereditary hemorrhagic telangiectasia","volume":"333","author":"Guttmacher","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpharm.2016.07.002_bib0085","doi-asserted-by":"crossref","first-page":"e465","DOI":"10.1016\/S2352-3026(15)00195-7","article-title":"Efficacy and safety of thalidomide for the treatment of severe recurrent epistaxis in hereditary hemorrhagic telangiectasia: results of a non-randomised single-centre, phase 2 study","volume":"2","author":"Invernizzi","year":"2015","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.ijpharm.2016.07.002_bib0090","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/03639040903170750","article-title":"The application of mucoadhesive polymers in nasal drug delivery","volume":"36","author":"Jiang","year":"2010","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2016.07.002_bib0095","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/03639040701484486","article-title":"Molecular encapsulation of thalidomide with sulfobutyl ether-7 beta-cyclodextrin for immediate release property: enhanced in vivo antitumor and antiangiogenesis efficacy in mice","volume":"34","author":"Kale","year":"2008","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2016.07.002_bib0100","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1208\/s12249-011-9739-2","article-title":"Preparation, characterization, and in vitro intestinal permeability evaluation of thalidomide-hydroxypropyl-beta-cyclodextrin complexes","volume":"13","author":"Kratz","year":"2012","journal-title":"AAPS PharmSciTech."},{"key":"10.1016\/j.ijpharm.2016.07.002_bib0105","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/jps.2600810719","article-title":"Improvements in solubility and stability of thalidomide upon complexation with hydroxypropyl-beta-cyclodextrin","volume":"81","author":"Krenn","year":"1992","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.07.002_bib0110","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nm.2131","article-title":"Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia","volume":"16","author":"Lebrin","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijpharm.2016.07.002_bib0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0378-5173(01)00761-X","article-title":"Cyclodextrins in topical drug formulations: theory and practice","volume":"225","author":"Loftsson","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.07.002_bib0120","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijpharm.2005.05.042","article-title":"Evaluation of cyclodextrin solubilization of drugs","volume":"302","author":"Loftsson","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.07.002_bib0125","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/10611869808997878","article-title":"Efficacy, safety and mechanism of cyclodextrins as absorption enhancers in nasal delivery of peptide and protein drugs","volume":"6","author":"Marttin","year":"1998","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ijpharm.2016.07.002_bib0130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0169-409X(98)00054-4","article-title":"Cyclodextrins in nasal drug delivery","volume":"36","author":"Merkus","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2016.07.002_bib0135","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.biopha.2012.08.006","article-title":"Evaluation of the effects of thalidomide-loaded biodegradable devices in solid Ehrlich tumor","volume":"67","author":"Pereira","year":"2013","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijpharm.2016.07.002_bib0140","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1773-2247(04)50083-7","article-title":"Chimeral agglomerates of microparticles for the administration of caffeine nasal powders","volume":"14","author":"Russo","year":"2004","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpharm.2016.07.002_bib0145","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/(SICI)1520-6017(200003)89:3<396::AID-JPS10>3.0.CO;2-F","article-title":"Validation of excised bovine nasal mucosa as in vitro model to study drug transport and metabolic pathways in nasal epithelium","volume":"89","author":"Schmidt","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.07.002_bib0150","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1476-5381.1965.tb02053.x","article-title":"The metabolism of thalidomide: the spontaneous hydrolysis of thalidomide in solution","volume":"25","author":"Schumacher","year":"1965","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"10.1016\/j.ijpharm.2016.07.002_bib0155","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0169-409X(97)00067-7","article-title":"Nasal delivery systems and their effect on deposition and absorption","volume":"29","author":"Vidgren","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2016.07.002_bib0160","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4414\/smw.2003.09947","article-title":"Thalidomide: from tragedy to promise","volume":"133","author":"von Moos","year":"2003","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.ijpharm.2016.07.002_bib0165","doi-asserted-by":"crossref","first-page":"19","DOI":"10.6028\/jres.053.003","article-title":"Relative humidity-temperature relationships of some saturated salt solutions in the temperature range 0\u00b0 to 50\u00b0C","volume":"53","author":"Wexler","year":"1954","journal-title":"J. Res. Natl. Stand."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316306329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316306329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:32:03Z","timestamp":1759915923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517316306329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0378517316306329"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.07.002","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nasal powders of thalidomide for local treatment of nose bleeding in persons affected by hereditary hemorrhagic telangiectasia","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}